Literature DB >> 18418639

Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women.

S Giroux1, L Elfassihi, D E C Cole, F Rousseau.   

Abstract

UNLABELLED: Replication is a critical step to validate positive genetic associations. In this study, we tested two previously reported positive associations. The low density lipoprotein receptor-related protein 5 (LRP5) Val667Met and lumbar spine bone density are replicated. This result is in line with results from large consortiums such as Genomos. However, the estrogen-related receptor alpha (ESRRA) repeat in the promoter is not replicated although the polymorphism studied was functional and could have been a causative variant.
INTRODUCTION: We sought to validate associations previously reported between LRP5 V667M polymorphism and lumbar spine (LS, p = 0.013) and femoral neck (FN, p = 0.0002) bone mineral density (BMD), and between ESRRA 23 base pair repeat polymorphism and LS BMD (p = 0.0036) in a sample of premenopausal Caucasian women using an independent sample.
METHODS: For the replication sample, we recruited 673 premenopausal women from the Toronto metropolitan area. All women were Caucasian and had BMD measured. LRP5 V667M was genotyped by allele-specific PCR and ESRRA repeats by sizing of PCR products on agarose gels.
RESULTS: We reproduced the same association as we reported previously between LRP5 V667M and LS BMD (p = 0.015) but not with FN BMD (p = 0.254). The combined data from the two populations indicate an effect size of 0.28SD for LS BMD (p = 0.00048) and an effect size of 0.26 SD for FN BMD (p = 0.00037). In contrast, the association we reported earlier between ESRRA repeats and LS BMD was not replicated in the sample from Toronto (p = 0.645).
CONCLUSIONS: The association between LRP5 V667M and LS BMD is confirmed but not that between ESRRA repeats and LS BMD. This result indicates that it is imperative to validate any positive association in an independent sample.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418639     DOI: 10.1007/s00198-008-0617-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  30 in total

Review 1.  Candidate-gene approaches for studying complex genetic traits: practical considerations.

Authors:  Holly K Tabor; Neil J Risch; Richard M Myers
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

2.  A clinical prediction rule to identify premenopausal women with low bone mass.

Authors:  G A Hawker; S A Jamal; R Ridout; C Chase
Journal:  Osteoporos Int       Date:  2002-05       Impact factor: 4.507

Review 3.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

4.  Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction.

Authors:  Dong-Hai Xiong; Hui Shen; Lan-Juan Zhao; Peng Xiao; Tie-Lin Yang; Yan Guo; Wei Wang; Yan-Fang Guo; Yong-Jun Liu; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-11       Impact factor: 6.741

5.  Contribution of the LRP5 gene to normal variation in peak BMD in women.

Authors:  Daniel L Koller; Shoji Ichikawa; Michelle L Johnson; Dongbing Lai; Xiaoling Xuei; Howard J Edenberg; P Michael Conneally; Siu L Hui; C Conrad Johnston; Munro Peacock; Tatiana Foroud; Michael J Econs
Journal:  J Bone Miner Res       Date:  2004-10-25       Impact factor: 6.741

6.  Direct haplotyping at the vitamin D receptor locus improves genetic resolution.

Authors:  V D Peltekova; L Rubin; A G Uitterlinden; G Hawker; R Vieth; H Trang; D E Cole
Journal:  J Bone Miner Res       Date:  1997-03       Impact factor: 6.741

7.  Genetic determinants of bone mass in adults. A twin study.

Authors:  N A Pocock; J A Eisman; J L Hopper; M G Yeates; P N Sambrook; S Eberl
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  A frequent regulatory variant of the estrogen-related receptor alpha gene associated with BMD in French-Canadian premenopausal women.

Authors:  Nathalie Laflamme; Sylvie Giroux; J Concepción Loredo-Osti; Latifa Elfassihi; Sylvie Dodin; Claudine Blanchet; Kenneth Morgan; Vincent Giguère; François Rousseau
Journal:  J Bone Miner Res       Date:  2005-02-07       Impact factor: 6.741

9.  Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.

Authors:  L A Rubin; G A Hawker; V D Peltekova; L J Fielding; R Ridout; D E Cole
Journal:  J Bone Miner Res       Date:  1999-04       Impact factor: 6.741

10.  The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro.

Authors:  E Bonnelye; L Merdad; V Kung; J E Aubin
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

View more
  9 in total

1.  Association of estrogen receptor β and estrogen-related receptor α gene polymorphisms with bone mineral density in postmenopausal women.

Authors:  Amira Shoukry; Sally M Shalaby; Rasha L Etewa; Hanan S Ahmed; Hossam M Abdelrahman
Journal:  Mol Cell Biochem       Date:  2015-04-24       Impact factor: 3.396

2.  Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans.

Authors:  Mathieu Ferron; Maya Boudiffa; Michel Arsenault; Mohamed Rached; Monica Pata; Sylvie Giroux; Latifa Elfassihi; Marina Kisseleva; Philip W Majerus; François Rousseau; Jean Vacher
Journal:  Cell Metab       Date:  2011-10-05       Impact factor: 27.287

Review 3.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

4.  Genetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures.

Authors:  Gregory J Tranah; Brent C Taylor; Li-Yung Lui; Joseph M Zmuda; Jane A Cauley; Kristine E Ensrud; Teresa A Hillier; Marc C Hochberg; Jia Li; Brian K Rhees; Henry A Erlich; Mark D Sternlicht; Gary Peltz; Steven R Cummings
Journal:  Calcif Tissue Int       Date:  2008-09-12       Impact factor: 4.333

5.  LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients.

Authors:  M Bernardes; C Durães; A Oliveira; M J Martins; R Lucas; L Costa; J G Pereira; I Ramos; J C Machado; F Simões-Ventura
Journal:  Osteoporos Int       Date:  2018-07-17       Impact factor: 4.507

Review 6.  Genetics of osteoporosis: accelerating pace in gene identification and validation.

Authors:  Wen-Feng Li; Shu-Xun Hou; Bin Yu; Meng-Meng Li; Claude Férec; Jian-Min Chen
Journal:  Hum Genet       Date:  2009-12-12       Impact factor: 4.132

7.  Involvement of the orphan nuclear estrogen receptor-related receptor α in osteoclast adhesion and transmigration.

Authors:  Edith Bonnelye; Frédéric Saltel; Anne Chabadel; Ralph A Zirngibl; Jane E Aubin; Pierre Jurdic
Journal:  J Mol Endocrinol       Date:  2010-09-14       Impact factor: 5.098

Review 8.  Estrogen-Related Receptor α: A Significant Regulator and Promising Target in Bone Homeostasis and Bone Metastasis.

Authors:  Chun Feng; Zhaowei Xu; Xiaojie Tang; Haifei Cao; Guilong Zhang; Jiangwei Tan
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

9.  Genetic analysis of the relationship between bone mineral density and low-density lipoprotein receptor-related protein 5 gene polymorphisms.

Authors:  Jiayong Yi; Yu Cai; Zhenjun Yao; Jianping Lin
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.